OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Targeting subcellular trafficking pathways for the design of therapeutic antibodies
Sally Ward completed her Ph.D. in the Department of Biochemistry at Cambridge University in the laboratory of Professor David Ellar. From 1988 to 1990, she carried out research on antibody repertoire technology in Sir Greg Winter’s laboratory at the MRC Laboratory of Molecular Biology in Cambridge. In 1990 she joined the University of Texas Southwestern Medical Center in Dallas as an Assistant Professor, and was appointed to the Paul and Betty Meek-FINA Professorship in Molecular Immunology at the same institution in 2004.
Sally was recently appointed Director of Translational Immunology and Professor of Molecular Immunology at the Centre for Cancer Immunology in Southampton, U.K. Her interdisciplinary research is carried out in collaboration with Raimund Ober and involves the use of a combination of protein engineering, fluorescence microscopy and in vivo studies to develop antibody-based technologies for the therapy of human disease. These approaches have been successfully translated to the clinic to increase the longevity of therapeutic antibodies and treat antibody-mediated autoimmunity.
Date:
3 March 2021, 13:00
Venue:
https://zoom.us/j/99641298801?pwd=YkFkWm9lK3ArU2hrZUl4YVE0RXdEUT09
Speaker:
Professor E. Sally Ward (University of Southampton)
Organising department:
Structural Genomics Consortium
Organiser:
Charlotte Morgan (University of Oxford)
Part of:
CMD Seminars
Booking required?:
Not required
Audience:
Public
Editor:
Charlotte Morgan
